Global CBD Nutraceuticals

CBD Nutraceuticals Comprehensive Study by Type (CBD Tinctures, Capsules & Softgels, CBD Gummies, Others), Application (Medical, Biomedical, Pharmaceutical, Nutraceutical) Players and Region - Global Market Outlook to 2030

CBD Nutraceuticals Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global CBD Nutraceuticals Market Overview:
The global CBD nutraceuticals market is expected to expand in the forecast period due to a growing consumer preference for plant-based supplements and rising awareness regarding the medical benefits of cannabidiol including its remedial properties. The industry continues to expand because of a variety of factors such as increasing acceptance of CBD for health and wellness purposes coupled with high bioavailability of tinctures when administered sublingually.

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Historical Period2018-2023
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Influencing Trend:
Increasing Approvals for Using CBD as Food Supplements

Market Growth Drivers:
Growing Demand for Hemp Protein among Athletes, Bodybuilders and Increasing Awareness Regarding the Health Benefits of Cannabidiol

Challenges:
Uncertain Government Regulations related to the Usage of CBD Food Supplements

Restraints:
Presence of Alternatives like the Herbal Nutraceuticals, such as Echinacea, and Turmeric and Fluctuating Prices of Raw Material

Opportunities:
Rising Consumer Preference for Plant-based Ingredients in Dietary Supplement and Growth in Developing Countries

Competitive Landscape:
Leading key players are focusing on strategic partnerships to improve their products and services. Companies are focusing on increasing their client base to strengthen market position and to enhance product & service offerings.
Some of the key players profiled in the report are Elixinol (United States), Medical Marijuana, Inc. (United States), CV Sciences, Inc. (United States), Irwin Naturals (United States), Diamond CBD (United States), Green Roads (United States), MEDTERRA (United States), Isodiol (Canada), Garden of Life (United States) and Foria Wellness (United States). Analyst at AMA Research see United States Vendors to retain maximum share of Global CBD Nutraceuticals market by 2030.

Latest Market Insights:
In April 2019, Australian biopharmaceutical firm, MGC Pharmaceuticals entered into a partnership with the Chinese e-commerce platform-YuShop Global for gaining entry in the Chinese CBD nutraceuticals space.

In April 2019, Aphria Inc. through its subsidiary Aphria Deutschland GmbH launched the Company's first CBD-based nutraceutical, the first product in its CBD-based cosmetics line for the German market. Featuring CBD derived from hemp, the CannRelief brand of products are being produced in the European Union and distributed by the Company's subsidiary, CC Pharma, which has access to more than 13,000 pharmacies throughout Germany.

What Can be Explored with the CBD Nutraceuticals Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global CBD Nutraceuticals Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in CBD Nutraceuticals
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global CBD Nutraceuticals market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in CBD Nutraceuticals market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes CBD Nutraceuticals Manufactures, CBD Nutraceuticals Suppliers, CBD Nutraceuticals Distributors, Government Regulatory Bodies, Private Research Organizations, Government Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • CBD Tinctures
  • Capsules & Softgels
  • CBD Gummies
  • Others
By Application
  • Medical
  • Biomedical
  • Pharmaceutical
  • Nutraceutical
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Demand for Hemp Protein among Athletes, Bodybuilders
      • 3.2.2. Increasing Awareness Regarding the Health Benefits of Cannabidiol
    • 3.3. Market Challenges
      • 3.3.1. Uncertain Government Regulations related to the Usage of CBD Food Supplements
    • 3.4. Market Trends
      • 3.4.1. Increasing Approvals for Using CBD as Food Supplements
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global CBD Nutraceuticals, by Type, Application and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global CBD Nutraceuticals (Value)
      • 5.2.1. Global CBD Nutraceuticals by: Type (Value)
        • 5.2.1.1. CBD Tinctures
        • 5.2.1.2. Capsules & Softgels
        • 5.2.1.3. CBD Gummies
        • 5.2.1.4. Others
      • 5.2.2. Global CBD Nutraceuticals by: Application (Value)
        • 5.2.2.1. Medical
        • 5.2.2.2. Biomedical
        • 5.2.2.3. Pharmaceutical
        • 5.2.2.4. Nutraceutical
      • 5.2.3. Global CBD Nutraceuticals Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
    • 5.3. Global CBD Nutraceuticals (Volume)
      • 5.3.1. Global CBD Nutraceuticals by: Type (Volume)
        • 5.3.1.1. CBD Tinctures
        • 5.3.1.2. Capsules & Softgels
        • 5.3.1.3. CBD Gummies
        • 5.3.1.4. Others
      • 5.3.2. Global CBD Nutraceuticals by: Application (Volume)
        • 5.3.2.1. Medical
        • 5.3.2.2. Biomedical
        • 5.3.2.3. Pharmaceutical
        • 5.3.2.4. Nutraceutical
      • 5.3.3. Global CBD Nutraceuticals Region
        • 5.3.3.1. South America
          • 5.3.3.1.1. Brazil
          • 5.3.3.1.2. Argentina
          • 5.3.3.1.3. Rest of South America
        • 5.3.3.2. Asia Pacific
          • 5.3.3.2.1. China
          • 5.3.3.2.2. Japan
          • 5.3.3.2.3. India
          • 5.3.3.2.4. South Korea
          • 5.3.3.2.5. Taiwan
          • 5.3.3.2.6. Australia
          • 5.3.3.2.7. Rest of Asia-Pacific
        • 5.3.3.3. Europe
          • 5.3.3.3.1. Germany
          • 5.3.3.3.2. France
          • 5.3.3.3.3. Italy
          • 5.3.3.3.4. United Kingdom
          • 5.3.3.3.5. Netherlands
          • 5.3.3.3.6. Rest of Europe
        • 5.3.3.4. MEA
          • 5.3.3.4.1. Middle East
          • 5.3.3.4.2. Africa
        • 5.3.3.5. North America
          • 5.3.3.5.1. United States
          • 5.3.3.5.2. Canada
          • 5.3.3.5.3. Mexico
    • 5.4. Global CBD Nutraceuticals (Price)
      • 5.4.1. Global CBD Nutraceuticals by: Type (Price)
  • 6. CBD Nutraceuticals: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Elixinol (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medical Marijuana, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. CV Sciences, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Irwin Naturals (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Diamond CBD (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Green Roads (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. MEDTERRA (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Isodiol (Canada)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Garden of Life (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Foria Wellness (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global CBD Nutraceuticals Sale, by Type, Application and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global CBD Nutraceuticals (Value)
      • 7.2.1. Global CBD Nutraceuticals by: Type (Value)
        • 7.2.1.1. CBD Tinctures
        • 7.2.1.2. Capsules & Softgels
        • 7.2.1.3. CBD Gummies
        • 7.2.1.4. Others
      • 7.2.2. Global CBD Nutraceuticals by: Application (Value)
        • 7.2.2.1. Medical
        • 7.2.2.2. Biomedical
        • 7.2.2.3. Pharmaceutical
        • 7.2.2.4. Nutraceutical
      • 7.2.3. Global CBD Nutraceuticals Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
    • 7.3. Global CBD Nutraceuticals (Volume)
      • 7.3.1. Global CBD Nutraceuticals by: Type (Volume)
        • 7.3.1.1. CBD Tinctures
        • 7.3.1.2. Capsules & Softgels
        • 7.3.1.3. CBD Gummies
        • 7.3.1.4. Others
      • 7.3.2. Global CBD Nutraceuticals by: Application (Volume)
        • 7.3.2.1. Medical
        • 7.3.2.2. Biomedical
        • 7.3.2.3. Pharmaceutical
        • 7.3.2.4. Nutraceutical
      • 7.3.3. Global CBD Nutraceuticals Region
        • 7.3.3.1. South America
          • 7.3.3.1.1. Brazil
          • 7.3.3.1.2. Argentina
          • 7.3.3.1.3. Rest of South America
        • 7.3.3.2. Asia Pacific
          • 7.3.3.2.1. China
          • 7.3.3.2.2. Japan
          • 7.3.3.2.3. India
          • 7.3.3.2.4. South Korea
          • 7.3.3.2.5. Taiwan
          • 7.3.3.2.6. Australia
          • 7.3.3.2.7. Rest of Asia-Pacific
        • 7.3.3.3. Europe
          • 7.3.3.3.1. Germany
          • 7.3.3.3.2. France
          • 7.3.3.3.3. Italy
          • 7.3.3.3.4. United Kingdom
          • 7.3.3.3.5. Netherlands
          • 7.3.3.3.6. Rest of Europe
        • 7.3.3.4. MEA
          • 7.3.3.4.1. Middle East
          • 7.3.3.4.2. Africa
        • 7.3.3.5. North America
          • 7.3.3.5.1. United States
          • 7.3.3.5.2. Canada
          • 7.3.3.5.3. Mexico
    • 7.4. Global CBD Nutraceuticals (Price)
      • 7.4.1. Global CBD Nutraceuticals by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. CBD Nutraceuticals: by Type(USD Million)
  • Table 2. CBD Nutraceuticals CBD Tinctures , by Region USD Million (2018-2023)
  • Table 3. CBD Nutraceuticals Capsules & Softgels , by Region USD Million (2018-2023)
  • Table 4. CBD Nutraceuticals CBD Gummies , by Region USD Million (2018-2023)
  • Table 5. CBD Nutraceuticals Others , by Region USD Million (2018-2023)
  • Table 6. CBD Nutraceuticals: by Application(USD Million)
  • Table 7. CBD Nutraceuticals Medical , by Region USD Million (2018-2023)
  • Table 8. CBD Nutraceuticals Biomedical , by Region USD Million (2018-2023)
  • Table 9. CBD Nutraceuticals Pharmaceutical , by Region USD Million (2018-2023)
  • Table 10. CBD Nutraceuticals Nutraceutical , by Region USD Million (2018-2023)
  • Table 11. South America CBD Nutraceuticals, by Country USD Million (2018-2023)
  • Table 12. South America CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 13. South America CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 14. Brazil CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 15. Brazil CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 16. Argentina CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 17. Argentina CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 18. Rest of South America CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 19. Rest of South America CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 20. Asia Pacific CBD Nutraceuticals, by Country USD Million (2018-2023)
  • Table 21. Asia Pacific CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 22. Asia Pacific CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 23. China CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 24. China CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 25. Japan CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 26. Japan CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 27. India CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 28. India CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 29. South Korea CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 30. South Korea CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 31. Taiwan CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 32. Taiwan CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 33. Australia CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 34. Australia CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 35. Rest of Asia-Pacific CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 36. Rest of Asia-Pacific CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 37. Europe CBD Nutraceuticals, by Country USD Million (2018-2023)
  • Table 38. Europe CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 39. Europe CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 40. Germany CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 41. Germany CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 42. France CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 43. France CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 44. Italy CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 45. Italy CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 46. United Kingdom CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 47. United Kingdom CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 48. Netherlands CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 49. Netherlands CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 50. Rest of Europe CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 51. Rest of Europe CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 52. MEA CBD Nutraceuticals, by Country USD Million (2018-2023)
  • Table 53. MEA CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 54. MEA CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 55. Middle East CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 56. Middle East CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 57. Africa CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 58. Africa CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 59. North America CBD Nutraceuticals, by Country USD Million (2018-2023)
  • Table 60. North America CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 61. North America CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 62. United States CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 63. United States CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 64. Canada CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 65. Canada CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 66. Mexico CBD Nutraceuticals, by Type USD Million (2018-2023)
  • Table 67. Mexico CBD Nutraceuticals, by Application USD Million (2018-2023)
  • Table 68. CBD Nutraceuticals Sales: by Type(K Unit)
  • Table 69. CBD Nutraceuticals Sales CBD Tinctures , by Region K Unit (2018-2023)
  • Table 70. CBD Nutraceuticals Sales Capsules & Softgels , by Region K Unit (2018-2023)
  • Table 71. CBD Nutraceuticals Sales CBD Gummies , by Region K Unit (2018-2023)
  • Table 72. CBD Nutraceuticals Sales Others , by Region K Unit (2018-2023)
  • Table 73. CBD Nutraceuticals Sales: by Application(K Unit)
  • Table 74. CBD Nutraceuticals Sales Medical , by Region K Unit (2018-2023)
  • Table 75. CBD Nutraceuticals Sales Biomedical , by Region K Unit (2018-2023)
  • Table 76. CBD Nutraceuticals Sales Pharmaceutical , by Region K Unit (2018-2023)
  • Table 77. CBD Nutraceuticals Sales Nutraceutical , by Region K Unit (2018-2023)
  • Table 78. South America CBD Nutraceuticals Sales, by Country K Unit (2018-2023)
  • Table 79. South America CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 80. South America CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 81. Brazil CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 82. Brazil CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 83. Argentina CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 84. Argentina CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 85. Rest of South America CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 86. Rest of South America CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 87. Asia Pacific CBD Nutraceuticals Sales, by Country K Unit (2018-2023)
  • Table 88. Asia Pacific CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 89. Asia Pacific CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 90. China CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 91. China CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 92. Japan CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 93. Japan CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 94. India CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 95. India CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 96. South Korea CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 97. South Korea CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 98. Taiwan CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 99. Taiwan CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 100. Australia CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 101. Australia CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 102. Rest of Asia-Pacific CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 103. Rest of Asia-Pacific CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 104. Europe CBD Nutraceuticals Sales, by Country K Unit (2018-2023)
  • Table 105. Europe CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 106. Europe CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 107. Germany CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 108. Germany CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 109. France CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 110. France CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 111. Italy CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 112. Italy CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 113. United Kingdom CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 114. United Kingdom CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 115. Netherlands CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 116. Netherlands CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 117. Rest of Europe CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 118. Rest of Europe CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 119. MEA CBD Nutraceuticals Sales, by Country K Unit (2018-2023)
  • Table 120. MEA CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 121. MEA CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 122. Middle East CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 123. Middle East CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 124. Africa CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 125. Africa CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 126. North America CBD Nutraceuticals Sales, by Country K Unit (2018-2023)
  • Table 127. North America CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 128. North America CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 129. United States CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 130. United States CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 131. Canada CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 132. Canada CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 133. Mexico CBD Nutraceuticals Sales, by Type K Unit (2018-2023)
  • Table 134. Mexico CBD Nutraceuticals Sales, by Application K Unit (2018-2023)
  • Table 135. CBD Nutraceuticals: by Type(USD/Units)
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. CBD Nutraceuticals: by Type(USD Million)
  • Table 147. CBD Nutraceuticals CBD Tinctures , by Region USD Million (2025-2030)
  • Table 148. CBD Nutraceuticals Capsules & Softgels , by Region USD Million (2025-2030)
  • Table 149. CBD Nutraceuticals CBD Gummies , by Region USD Million (2025-2030)
  • Table 150. CBD Nutraceuticals Others , by Region USD Million (2025-2030)
  • Table 151. CBD Nutraceuticals: by Application(USD Million)
  • Table 152. CBD Nutraceuticals Medical , by Region USD Million (2025-2030)
  • Table 153. CBD Nutraceuticals Biomedical , by Region USD Million (2025-2030)
  • Table 154. CBD Nutraceuticals Pharmaceutical , by Region USD Million (2025-2030)
  • Table 155. CBD Nutraceuticals Nutraceutical , by Region USD Million (2025-2030)
  • Table 156. South America CBD Nutraceuticals, by Country USD Million (2025-2030)
  • Table 157. South America CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 158. South America CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 159. Brazil CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 160. Brazil CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 161. Argentina CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 162. Argentina CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 163. Rest of South America CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 164. Rest of South America CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 165. Asia Pacific CBD Nutraceuticals, by Country USD Million (2025-2030)
  • Table 166. Asia Pacific CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 167. Asia Pacific CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 168. China CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 169. China CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 170. Japan CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 171. Japan CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 172. India CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 173. India CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 174. South Korea CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 175. South Korea CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 176. Taiwan CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 177. Taiwan CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 178. Australia CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 179. Australia CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 180. Rest of Asia-Pacific CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 181. Rest of Asia-Pacific CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 182. Europe CBD Nutraceuticals, by Country USD Million (2025-2030)
  • Table 183. Europe CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 184. Europe CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 185. Germany CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 186. Germany CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 187. France CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 188. France CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 189. Italy CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 190. Italy CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 191. United Kingdom CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 192. United Kingdom CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 193. Netherlands CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 194. Netherlands CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 195. Rest of Europe CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 196. Rest of Europe CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 197. MEA CBD Nutraceuticals, by Country USD Million (2025-2030)
  • Table 198. MEA CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 199. MEA CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 200. Middle East CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 201. Middle East CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 202. Africa CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 203. Africa CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 204. North America CBD Nutraceuticals, by Country USD Million (2025-2030)
  • Table 205. North America CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 206. North America CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 207. United States CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 208. United States CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 209. Canada CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 210. Canada CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 211. Mexico CBD Nutraceuticals, by Type USD Million (2025-2030)
  • Table 212. Mexico CBD Nutraceuticals, by Application USD Million (2025-2030)
  • Table 213. CBD Nutraceuticals Sales: by Type(K Unit)
  • Table 214. CBD Nutraceuticals Sales CBD Tinctures , by Region K Unit (2025-2030)
  • Table 215. CBD Nutraceuticals Sales Capsules & Softgels , by Region K Unit (2025-2030)
  • Table 216. CBD Nutraceuticals Sales CBD Gummies , by Region K Unit (2025-2030)
  • Table 217. CBD Nutraceuticals Sales Others , by Region K Unit (2025-2030)
  • Table 218. CBD Nutraceuticals Sales: by Application(K Unit)
  • Table 219. CBD Nutraceuticals Sales Medical , by Region K Unit (2025-2030)
  • Table 220. CBD Nutraceuticals Sales Biomedical , by Region K Unit (2025-2030)
  • Table 221. CBD Nutraceuticals Sales Pharmaceutical , by Region K Unit (2025-2030)
  • Table 222. CBD Nutraceuticals Sales Nutraceutical , by Region K Unit (2025-2030)
  • Table 223. South America CBD Nutraceuticals Sales, by Country K Unit (2025-2030)
  • Table 224. South America CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 225. South America CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 226. Brazil CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 227. Brazil CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 228. Argentina CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 229. Argentina CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 230. Rest of South America CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 231. Rest of South America CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 232. Asia Pacific CBD Nutraceuticals Sales, by Country K Unit (2025-2030)
  • Table 233. Asia Pacific CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 234. Asia Pacific CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 235. China CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 236. China CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 237. Japan CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 238. Japan CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 239. India CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 240. India CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 241. South Korea CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 242. South Korea CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 243. Taiwan CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 244. Taiwan CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 245. Australia CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 246. Australia CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 247. Rest of Asia-Pacific CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 248. Rest of Asia-Pacific CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 249. Europe CBD Nutraceuticals Sales, by Country K Unit (2025-2030)
  • Table 250. Europe CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 251. Europe CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 252. Germany CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 253. Germany CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 254. France CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 255. France CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 256. Italy CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 257. Italy CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 258. United Kingdom CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 259. United Kingdom CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 260. Netherlands CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 261. Netherlands CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 262. Rest of Europe CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 263. Rest of Europe CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 264. MEA CBD Nutraceuticals Sales, by Country K Unit (2025-2030)
  • Table 265. MEA CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 266. MEA CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 267. Middle East CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 268. Middle East CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 269. Africa CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 270. Africa CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 271. North America CBD Nutraceuticals Sales, by Country K Unit (2025-2030)
  • Table 272. North America CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 273. North America CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 274. United States CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 275. United States CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 276. Canada CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 277. Canada CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 278. Mexico CBD Nutraceuticals Sales, by Type K Unit (2025-2030)
  • Table 279. Mexico CBD Nutraceuticals Sales, by Application K Unit (2025-2030)
  • Table 280. CBD Nutraceuticals: by Type(USD/Units)
  • Table 281. Research Programs/Design for This Report
  • Table 282. Key Data Information from Secondary Sources
  • Table 283. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global CBD Nutraceuticals: by Type USD Million (2018-2023)
  • Figure 5. Global CBD Nutraceuticals: by Application USD Million (2018-2023)
  • Figure 6. South America CBD Nutraceuticals Share (%), by Country
  • Figure 7. Asia Pacific CBD Nutraceuticals Share (%), by Country
  • Figure 8. Europe CBD Nutraceuticals Share (%), by Country
  • Figure 9. MEA CBD Nutraceuticals Share (%), by Country
  • Figure 10. North America CBD Nutraceuticals Share (%), by Country
  • Figure 11. Global CBD Nutraceuticals: by Type K Unit (2018-2023)
  • Figure 12. Global CBD Nutraceuticals: by Application K Unit (2018-2023)
  • Figure 13. South America CBD Nutraceuticals Share (%), by Country
  • Figure 14. Asia Pacific CBD Nutraceuticals Share (%), by Country
  • Figure 15. Europe CBD Nutraceuticals Share (%), by Country
  • Figure 16. MEA CBD Nutraceuticals Share (%), by Country
  • Figure 17. North America CBD Nutraceuticals Share (%), by Country
  • Figure 18. Global CBD Nutraceuticals: by Type USD/Units (2018-2023)
  • Figure 19. Global CBD Nutraceuticals share by Players 2023 (%)
  • Figure 20. Global CBD Nutraceuticals share by Players (Top 3) 2023(%)
  • Figure 21. Global CBD Nutraceuticals share by Players (Top 5) 2023(%)
  • Figure 22. BCG Matrix for key Companies
  • Figure 23. Elixinol (United States) Revenue, Net Income and Gross profit
  • Figure 24. Elixinol (United States) Revenue: by Geography 2023
  • Figure 25. Medical Marijuana, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Medical Marijuana, Inc. (United States) Revenue: by Geography 2023
  • Figure 27. CV Sciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. CV Sciences, Inc. (United States) Revenue: by Geography 2023
  • Figure 29. Irwin Naturals (United States) Revenue, Net Income and Gross profit
  • Figure 30. Irwin Naturals (United States) Revenue: by Geography 2023
  • Figure 31. Diamond CBD (United States) Revenue, Net Income and Gross profit
  • Figure 32. Diamond CBD (United States) Revenue: by Geography 2023
  • Figure 33. Green Roads (United States) Revenue, Net Income and Gross profit
  • Figure 34. Green Roads (United States) Revenue: by Geography 2023
  • Figure 35. MEDTERRA (United States) Revenue, Net Income and Gross profit
  • Figure 36. MEDTERRA (United States) Revenue: by Geography 2023
  • Figure 37. Isodiol (Canada) Revenue, Net Income and Gross profit
  • Figure 38. Isodiol (Canada) Revenue: by Geography 2023
  • Figure 39. Garden of Life (United States) Revenue, Net Income and Gross profit
  • Figure 40. Garden of Life (United States) Revenue: by Geography 2023
  • Figure 41. Foria Wellness (United States) Revenue, Net Income and Gross profit
  • Figure 42. Foria Wellness (United States) Revenue: by Geography 2023
  • Figure 43. Global CBD Nutraceuticals: by Type USD Million (2025-2030)
  • Figure 44. Global CBD Nutraceuticals: by Application USD Million (2025-2030)
  • Figure 45. South America CBD Nutraceuticals Share (%), by Country
  • Figure 46. Asia Pacific CBD Nutraceuticals Share (%), by Country
  • Figure 47. Europe CBD Nutraceuticals Share (%), by Country
  • Figure 48. MEA CBD Nutraceuticals Share (%), by Country
  • Figure 49. North America CBD Nutraceuticals Share (%), by Country
  • Figure 50. Global CBD Nutraceuticals: by Type K Unit (2025-2030)
  • Figure 51. Global CBD Nutraceuticals: by Application K Unit (2025-2030)
  • Figure 52. South America CBD Nutraceuticals Share (%), by Country
  • Figure 53. Asia Pacific CBD Nutraceuticals Share (%), by Country
  • Figure 54. Europe CBD Nutraceuticals Share (%), by Country
  • Figure 55. MEA CBD Nutraceuticals Share (%), by Country
  • Figure 56. North America CBD Nutraceuticals Share (%), by Country
  • Figure 57. Global CBD Nutraceuticals: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Elixinol (United States)
  • Medical Marijuana, Inc. (United States)
  • CV Sciences, Inc. (United States)
  • Irwin Naturals (United States)
  • Diamond CBD (United States)
  • Green Roads (United States)
  • MEDTERRA (United States)
  • Isodiol (Canada)
  • Garden of Life (United States)
  • Foria Wellness (United States)
Select User Access Type

Key Highlights of Report


Feb 2024 203 Pages 87 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global CBD Nutraceuticals Quantitative research analysis
Global CBD Nutraceuticals Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global CBD Nutraceuticals market are Elixinol (United States), Medical Marijuana, Inc. (United States), CV Sciences, Inc. (United States), Irwin Naturals (United States), Diamond CBD (United States), Green Roads (United States), MEDTERRA (United States), Isodiol (Canada), Garden of Life (United States) and Foria Wellness (United States), to name a few.
"Increasing Approvals for Using CBD as Food Supplements" is seen as one of major influencing trends for CBD Nutraceuticals Market during projected period 2023-2030.
CBD Tinctures segment in Global market to hold robust market share owing to "Growing Demand for Hemp Protein among Athletes, Bodybuilders ".

Know More About Global CBD Nutraceuticals Report?

Have a Query? Click Here

Other Related Reports

Cultured Dairy Blend Comprehensive Study by Type (Buttermilk, Cheese, Sour Cream, Yogurt, Milk Products), Nature (Organic, Conventional), Sales Channel (Online, Offline), Flavor (Vanilla, Strawberry,...
$ 3500
Ginger Root Extract Comprehensive Study by Application (Food Products, Medical Products, Cosmetic Products, Other), Nature (Organic, Conventional), Form (Oil, Powder), Distribution Channel (Online, O...
$ 3500
Red Berries Comprehensive Study by Type (Cranberry, Strawberry, Red Raspberry, Cherry, Grapes, Red Currants), Application (Dairy, Bakery & Confectionery, Beverages, Snack Food, Nutraceuticals, Sauces...
$ 3650
Ice Cream Cones Comprehensive Study by Type (Waffle Cone, Cake or Wafer Cone, Pretzel Cone, Sugar Cone, Chocolate-coated Cone, Double Cone, Vanilla Cone), Application (Cafes, Restaurants, Household, ...
$ 3650
India Namkeen Comprehensive Study by Raw Material (Gram Flour, Potatoes, Rice Flakes, Lentils, Others), Distribution Channels (Supermarkets and Hypermarkets, Convenience Stores, Specialty Stores, Onl...
$ 3450
Ice Cream Bar Comprehensive Study by Type (Vanilla Ice Cream, Chocolate Ice Cream, Other), Application (Residential, Commercial), Size (Mini, Regular, Others), Distribution channel (Online, Offline) ...
$ 3500